4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0000950170-24-019044
Chief Legal Officer sold 7,606 shares at $0.68 ($5,172)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wilson Mark Andrew Chief Legal Officer | 2024-02-20 | Sale | −7,606 | $0.68 | $5,172 | 236,674 | D: show line 1 in the form |
| Open-market sales · 7,606 sh · avg $0.68 · $5,172 | |||||||
Loading xslF345X05/ownership.xml…